Drug Delivery
The Drug Delivery Special Interest Group will deal with the science and technology of controlled release of active agents from delivery systems. Controlled drug release is achieved by the use of diffusion, chemical reactions, dissolutions or osmosis, used either singly or in combination. While the vast majority of such delivery devices are based on polymers, controlled release can also be achieved by the use of mechanical pumps. In a broader sense, controlled release also involves control over the site of action of the active agent, using the active agent using pro-drugs, targetable water soluble polymers or various microparticulate systems. Relevant aspects of toxicology, bioavailability, pharmacokinetics, and biocompatibility are also included.
Objectives:
- Provide forums for presentations and exchange of knowledge at SFB through sponsoring symposia and sessions.
- Publicize member activities in the Biomaterials Forum.
- Provide career and professional development resources through networking and mentoring relationships to facilitate career transitions from graduate school to industrial and academic careers and beyond.
- Establish stronger interactions with members in the SIG, other SIGs, and other professional societies.
Activities
- suggesting, organizing, and implementing symposia, workshops, tutorials, and general scientific sessions at the SFB Annual Meeting and other SFB-sponsored meetings
- providing networking opportunities for researchers who work at the interface of pharmaceutical science, drug delivery and biomaterials
- promoting interactions between academia, clinicians, government, and industry in areas that impact drug delivery
- generating a one stop resource for funding opportunities and needs to better match drug delivery researchers with the funding agencies
- enhancing education in the area of biomaterials and drug delivery, by contributing articles to relevant publications, sharing educational materials and organizing educational sessions at meetings
- collaborating with other SIGs to further the goals of the Society as a whole, and to promote advances in biomedical materials research in a broad range of applications
Officers
Chair: Michael John Mitchell, PhD
Associate Professor
University of Pennsylvania
240 Skirkanich Hall
210 S. 33rd Street
Philadelphia, PA 19104
t: 215.898.0882
e: mjmitch@seas.upenn.edu
Vice Chair: Omid Veiseh, PhD
Rice University
6500 Main ST
Houston, TX 77030
t: (206) 915-7502
e: omid.veiseh@gmail.com
Secretary/Treasurer: Ana Jaklenec, PhD
MIT
500 Main Street
76-661
Cambridge, MA 02139
e: jaklenec@mit.edu
Program Chair: Ambika Bajpayee, PhD
Northeastern University
805 Columbus Ave
Boston, MA
t: (617) 388-2449
e: a.bajpayee@neu.edu
Web Representative: Daniel Hachim, Ph.D
McGowan Institute/University of Pittsburgh
450 Technology Drive, Suite 323.4
Pittsburgh, PA 15219
t: (412) 328-0750
e: djh88@pitt.edu
PostDoc Representative: Marian Ackun-Farmmer, PhD
University of Maryland
e: mackunfa@umd.edu
Student Representative: Brett Pogostin
Rice University
e: bp22@rice.edu
Biomaterials Forum Reporter: Eun Ji Chung, PhD
Assistant Professor
University of Southern California
1042 Downey Way, DRB 314
Los Angeles, CA 90089-1111
t: (213) 740-2925
e: eunchung@usc.edu
Past Chair: Noelle Comolli, PhD
Associate Professor
Villanova University
Chemical Engineering
800 Lancaster Ave
Villanova, PA 19085
t: (610) 519-7134
e: noelle.comolli@villanova.edu
Click here for membership list (member log-in required - only available to members of this committee)